Plasma levels of IL-1β and IL-37 in patients with severe haemophilia.

The Journal of International Medical Research
Pei-Chin LinYu-Hsin Tseng

Abstract

Haemophilia A and B are disorders caused by the lack of clotting factors VIII and IX, respectively. Repeated bleeding into the same joint leads to haemophilic arthropathy (HA). Interleukin (IL)-1β is responsible for the pro-inflammatory response and IL-37 is induced by IL-1β stimuli to have an anti-inflammatory response and prevent uncontrolled inflammation and tissue damage. Our objective was to investigate plasma levels of IL-1β and IL-37 in patients with severe haemophilia with different severities of HA. Peripheral blood samples were collected from 14 patients with severe haemophilia A and 6 with severe haemophilia B, and 18 healthy individuals. Plasma levels of IL-1β and IL-37 were detected by immunoassay, and severity of HA was evaluated using the Pettersson scoring system. Plasma levels of IL-1β and IL-37 were analysed in patients with severe haemophilia grouped by Pettersson score and in healthy individuals. Plasma levels of IL-1β and IL-37 were significantly higher in patients with severe haemophilia compared with healthy individuals and significantly lower in those with moderate to severe HA than in those with no or mild HA. Plasma levels of IL-1β and IL-37 may be useful to track HA progression in patients with severe...Continue Reading

References

Feb 17, 1979·British Medical Journal·A AronstamM J Painter
Apr 1, 2000·The Journal of Biological Chemistry·S KumarP R Young
Aug 8, 2009·Haemophilia : the Official Journal of the World Federation of Hemophilia·D StephensenM Winter
Jan 11, 2014·Current Rheumatology Reports·Naomi Schlesinger
Feb 19, 2014·Haemophilia : the Official Journal of the World Federation of Hemophilia·P TeysslerV Bobek
Apr 29, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Liang YeZhong Huang
Nov 7, 2015·Blood·Alok Srivastava
Nov 10, 2015·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Libin YangTan Lu
Apr 4, 2017·Haemophilia : the Official Journal of the World Federation of Hemophilia·J HanleyUNKNOWN Musculoskeletal Working Party of the UKHCDO
Apr 26, 2017·Haemophilia : the Official Journal of the World Federation of Hemophilia·B HuaT Manon-Jensen
Jul 1, 2017·Orthopedics·Christopher R NaccaJohn R Tuttle
Nov 21, 2017·Cytokine & Growth Factor Reviews·Piotr WojdasiewiczRobert Gasik
Dec 17, 2017·Immunological Reviews·Giulio Cavalli, Charles A Dinarello
Dec 17, 2017·Immunological Reviews·Charles A Dinarello
May 29, 2018·BioMed Research International·Hailin JiaBo Han
Jun 8, 2018·Thrombosis Research·Isabella GaragiolaFlora Peyvandi
Nov 9, 2018·Haemophilia : the Official Journal of the World Federation of Hemophilia·Martin J ScottCharles R M Hay
Mar 16, 2019·International Journal of Molecular Sciences·Marie-Astrid BoutetCostantino Pitzalis

❮ Previous
Next ❯

Methods Mentioned

BETA
Assay

Software Mentioned

GraphPad Prism

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.